303
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies

, , , , , , & show all
Pages 922-936 | Received 13 Oct 2018, Accepted 02 Feb 2019, Published online: 27 Feb 2019

References

  • Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bulletin WHO. 2001;79:214–221.
  • O'Brien TP. Therapy of ocular fungal infections. Ophthalmol Clin. 1999;12:33–50.
  • Manger, T, T, Mauger E. Craig Havener's Ocular Pharmacology. 9th ed. St. Louis (MO): C. V. Mosby; 1994.
  • Raab W. Natamycin (pimaricin): its properties and possibilities in medicine. Stuttgart (Germany): Georg Thieme Publishers; 1972.
  • Chandasana H, Prasad YD, Chhonker YS, et al. Corneal targeted nanoparticles for sustained natamycin delivery and their PK/PD indices: an approach to reduce dose and dosing frequency. Int J Pharm. 2014;477:317–325.
  • Patil A, Lakhani P, Majumdar S. Current perspectives on natamycin in ocular fungal infections. J Drug Deliv Sci Technol. 2017;41:206–212.
  • Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011;1:208–219.
  • Bendas ER, Abdullah H, El-Komy MH, et al. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Int J Pharm. 2013;458:287–295.
  • Carafa M, Santucci E, Alhaique F, et al. Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles. Int J Pharm. 1998;160:51–59.
  • Cortesi R, Esposito E, Corradini F, et al. Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies. Int J Pharm. 2007;339:52–60.
  • Balakrishnan P, Shanmugam S, Lee WS, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm. 2009;377:1–8.
  • Abdelkader H, Wu Z, Al-Kassas R, et al. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm. 2012;433:142–148.
  • Palozza P, Muzzalupo R, Trombino S, et al. Solubilization and stabilization of beta-carotene in niosomes: delivery to cultured cells . Chem Phys Lipids. 2006;139:32–42.
  • Biju S, S, Talegaonkar P, Mishra R, et al. Vesicular systems: an overview. Indian JPharm Sci. 2006;68.
  • Shirsand S, Para M, Nagendrakumar D, et al. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. Int J Pharma Investig. 2012;2:201–207.
  • Mohsen AM, AbouSamra MM, ElShebiney SA. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation. Drug Dev Ind Pharm. 2017;43:1254–1264.
  • Bhatta R, Chandasana H, Chhonker Y, et al. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies. Int J Pharm. 2012;432:105–112.
  • Phan CM, Subbaraman L, Liu S, et al. In vitro uptake and release of natamycin Dex-b-PLA nanoparticles from model contact lens materials. J Biomater Sci Polym Ed. 2014;25:18–31.
  • Paradkar MU, Parmar M. Formulation development and evaluation of Natamycin niosomal in-situ gel for ophthalmic drug delivery. J Drug Deliv Sci Technol. 2017;39:113–122.
  • Lang JC, Roehrs RE, Rodeheaver DP, et al. Design and evaluation of ophthalmic pharmaceutical products. Drug Pharm Sci. 2002;121:415–478.
  • El-Mofty HM, Abdelhakim MASE, El-Miligi MF, et al. A new combination formula for treatment of fungal keratitis: an experimental study. J Ophthalmol. 2014;2014:1–7.
  • Martindale. 35th ed. London: PhP Pharmaceutical Press; 2007.
  • Alem MA, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemoth. 2004;48:41–47.
  • Bandara B, Sankaridurg P, Willcox M. Non-steroidal anti inflammatory agents decrease bacterial colonisation of contact lenses and prevent adhesion to human corneal epithelial cells. Curr Eye Res. 2004;29:245–251.
  • Szoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A. 1978;75:4194–4198.
  • Hosny KM. Ciprofloxacin as ocular liposomal hydrogel. AAPS PharmSciTech. 2010;11:241–246.
  • Zeng X, Danquah MK, Jing K, et al. Solubility properties and diffusional extraction behavior of natamycin from Streptomyces gilvosporeus biomass. Biotechnol Progress. 2013;29:109–115.
  • Luo J, Z, Jin P, Cen M, et al. Determination and correlation of natamycin solubilities in water and methanol. J Chem Ind Eng China. 2008;59:281.
  • El-Nabarawi MA, Bendas ER, El Rehem RTA, et al. Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. Int J Pharm. 2013;443:307–317.
  • Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm. 2005;290:155–159.
  • Jain RL, Shastri J. Study of ocular drug delivery system using drug-loaded liposomes. Int J Pharma Investig. 2011;1:35.
  • Pham TT, Jaafar-Maalej C, Charcosset C, et al. Liposome and niosome preparation using a membrane contactor for scale-up. Colloids Surf B Biointerfaces. 2012;94:15–21.
  • Wu ZH, Ping QN, Wei Y, et al. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. Acta Pharmacol Sin. 2004;25:966–972.
  • Marianecci C, Paolino D, Celia C, et al. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release. 2010;147:127–135.
  • El-Samaligy M, Afifi N, Mahmoud E. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm. 2006;308:140–148.
  • Junyaprasert VB, Teeranachaideekul V, Supaperm T. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS PharmSciTech. 2008;9:851.
  • Kakkar S, Karuppayil SM, Raut JS, et al. Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole. Int J Pharm. 2015;495:276–289.
  • Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
  • Dash S, Murthy PN, Nath L, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67:217–223.
  • Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328:130–141.
  • Ocaña J, Frutos G, Sánchez P. Using the similarity factor f2 in practice: A critical revision and suggestions for its standard error estimation. Chemometrics Intel Lab Sys. 2009;99:49–56.
  • Costa P. An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharm. 2001;220:77–83.
  • Kaur H, Yadav S, Ahuja M, et al. Synthesis, characterization and evaluation of thiolated tamarind seed polysaccharide as a mucoadhesive polymer. Carbohydr Polym. 2012;90:1543–1549.
  • Bansal K, Rawat M, Jain A, et al. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech. 2009;10:716.
  • Kamal AH, El-Malla SF, Hammad SF. A review on UV spectrophotometric methods for simultaneous multicomponent analysis. Eur J Pharm Med Res. 2016;3:348–360.
  • Ražem D, Katušin-Ražem B. The effects of irradiation on controlled drug delivery/controlled drug release systems. Rad Phys Chem. 2008;77:288–344.
  • Hathout RM, Mansour S, Mortada ND, et al. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech. 2007;8:1–12.
  • Nesseem DI. Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. J Pharm Biomed Anal. 2001;26:387–399.
  • Fetih G. Fluconazole-loaded niosomal gels as a topical ocular drug delivery system for corneal fungal infections. J Drug Deliv Sci Technol. 2016;35:8–15.
  • Hindler J, Howard B, Keiser J. Antimicrobial agents and antimicrobial susceptibility testing. In: Howard BJ. Clinical and Pathogenic Microbiology. 2nd ed. St. Louis (MO): Mosby; 1994.
  • Tayel SA, El-Nabarawi MA, Tadros MI, et al. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm. 2013;443:293–305.
  • Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exper Ther. 1944;82:377–390.
  • Guinedi AS, Mortada ND, Mansour S, et al. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005;306:71–82.
  • El-Ridy MS, Abdelbary A, Essam T, et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Dev Ind Pharm. 2011;37:1491–1508.
  • Kashi TSJ, Eskandarion S, Esfandyari-Manesh M, et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine. 2012;7:221–234.
  • Cevher E, Şensoy D, Zloh M, et al. Preparation and characterisation of natamycin: γ-cyclodextrin inclusion complex and its evaluation in vaginal mucoadhesive formulations. J Pharm Sci. 2008;97:4319–4335.
  • Nasr M, Mansour S, Mortada ND, et al. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul. 2008;25:499–512.
  • El-Ridy MS, Badawi AA, Safar MM, et al. Niosomes as a novel pharmaceutical formulation encapsulating the hepatoprotective drug silymarin. Int J Pharm Pharm Sci. 2012;4:549–559.
  • Hasan AA, Madkor H, Wageh S. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv. 2013;20:120–126.
  • El-Gazayerly ON, Hikal AH. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm. 1997;158:121–127.
  • Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104–111.
  • Jones DS, Woolfson AD, Brown AF, et al. Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Release. 2000;67:357–368.
  • Habib F, M, Abdel Azeem G, Fetih M, et al. Mucoadhesive buccal patches of lornoxicam: development and in-vitro characterization. Bull Pharm Sci Assiut Univ. 2010;33:59–68.
  • Baloğlu E, Özyazıcı M, Yaprak Hızarcıoğlu S, et al. Bioadhesive controlled release systems of ornidazole for vaginal delivery. Pharm Deve Technol. 2006;11:477–484.
  • Hoare TR, Kohane DS. Hydrogels in drug delivery: progress and challenges. Polymer. 2008;49:1993–2007.
  • Jones DS, Woolfson AD, Brown AF. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm. 1997;151:223–233.
  • Attia DA. In vitro and in vivo evaluation of transdermal absorption of naproxen sodium. Aust J Basic Appl Sci. 2009;3:2154–2165.
  • Conti S, Maggi L, Segale L, et al. Matrices containing NaCMC and HPMC: 1. Dissolution performance characterization. Int J Pharm. 2007;333:136–142.
  • Ozturk F, Yavas GF, Kusbeci T, et al. Efficacy of topical caspofungin in experimental Fusarium keratitis. Cornea. 2007;26:726–728.
  • Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res. 2011;36:179–189.
  • Manjappa A, Nanjwade BK, Manvi F, et al. Sustained ophthalmic in situ gel of ketorolac tromethamine: rheology and in vivo studies. Drug Dev Res. 2009;70:417–424.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.